Zobrazeno 1 - 10
of 13
pro vyhledávání: '"John M. Coster"'
Autor:
John M. Coster
Publikováno v:
American Journal of Health-System Pharmacy. 49:1759-1762
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5825df289ed6214c4badefd7237b630
https://doi.org/10.1093/ajhp/49.7.1759
https://doi.org/10.1093/ajhp/49.7.1759
Autor:
John M. Coster
Publikováno v:
International Journal of Technology Assessment in Health Care. 8:635-646
The U.S. Food and Drug Administration's (FDA) approval of the orphan biological product recombinant erythropoietin (rEPO) in June 1989 resulted both in a breakthrough treatment for the chronic anemia of people who suffer from chronic renal failure an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ec68cfad21b2173545a2bb158fc1a6
https://doi.org/10.1017/s0266462300002336
https://doi.org/10.1017/s0266462300002336
Autor:
Michael R. Pollard, John M. Coster
Publikováno v:
Health Affairs. 10:196-206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4263643d87850f84466f6998191de4d
https://doi.org/10.1377/hlthaff.10.2.196
https://doi.org/10.1377/hlthaff.10.2.196
Publikováno v:
Biomedical Ethics Reviews · 1989 ISBN: 9781475746389
One may tend to think of biomedical ethics issues from a noneconomic perspective, i.e., rights and responsibilities, life and death, situational “oughts.” Yet, as an interdisciplinary forum, biomedical ethics at times rubs shoulders with business
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::870ac9bb5361c658ae7495d3f8f00ef1
https://doi.org/10.1007/978-1-59259-444-3_4
https://doi.org/10.1007/978-1-59259-444-3_4
Autor:
Michael R. Pollard, John M. Coster
Publikováno v:
Health Affairs. 11:287-287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d1d58bd94e21cfe6aef89ca40fc106
https://doi.org/10.1377/hlthaff.11.1.287
https://doi.org/10.1377/hlthaff.11.1.287
Publikováno v:
JAMA: The Journal of the American Medical Association. 266:2706
In Reply. —We have read with interest Dr Eggers' comments on our article. The article commended rather than criticized the HCFA for its initial payment policy. We expressed concern not with the initial policy but with its monitoring and refinement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a441d0f5c4514c81169b7c24348d0353
https://doi.org/10.1001/jama.1991.03470190053027
https://doi.org/10.1001/jama.1991.03470190053027
Autor:
John M. Coster
Publikováno v:
American Journal of Health-System Pharmacy. 43:850-861
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7dbaf4c66d0f34ad12827df4ef92140
https://doi.org/10.1093/ajhp/43.4.850
https://doi.org/10.1093/ajhp/43.4.850
Autor:
John M. Coster
Publikováno v:
American Journal of Health-System Pharmacy. 42:2409-2413
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dfb3a1baa2999373efc8e0b6990b22b
https://doi.org/10.1093/ajhp/42.11.2409
https://doi.org/10.1093/ajhp/42.11.2409
Autor:
John M. Coster
Publikováno v:
American Pharmacy. 23:40-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26f94d976b7a487572266702b6209a88
https://doi.org/10.1016/s0160-3450(16)32130-4
https://doi.org/10.1016/s0160-3450(16)32130-4
Autor:
John M. Coster
Publikováno v:
American pharmacy. (9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad90748fe45c37cb7542e521d04ee2f
https://pubmed.ncbi.nlm.nih.gov/7282540
https://pubmed.ncbi.nlm.nih.gov/7282540